Structure/Function Claim Notification for Dietary Supplements
The Federal Food, Drug, and Cosmetic Act (the Act) requires that the manufacturer, packer, or distributor who wish to market a dietary supplement notify FDA regarding the statement on the label or in the labeling of its product, pursuant to § 403(r)(6) of the Act.
The law states that a dietary supplement may bear certain statements on its label or in its labeling
- if the claim(s) meets certain requirements,
- if the entities making the claims have substantiation that such a statement is truthful and not misleading, and if
- the standard disclaimer (see § 403(r)(6)(C)) is prominently displayed on the label.
Section 101.93(f) of the Code of Federal Regulations (CFR), Title 21, simply restates part of the definition of the types of claims that may be made under section 403(r)(6) of the Act.
Finally, the notification must be submitted to FDA no later than 30 days after the first marketing of the dietary supplement product.
Read more on the definition of Structure/Function Label Claims.
Submitting Notification
Electronic Submissions
FDA provides an ePortal (COSM) for electronic submissions. We encourage submitters to utilize the portal in order to receive confirmation of receipt by FDA and to facilitate their review.
Launch the Structure/Function Claim Notification ePortal
(via the CFSAN Online Submission Module)
** instructions and account management information available **
Change in the Submission Process from FURLS to COSM
**IMPORTANT: As of October 19, 2019, notifications are no longer being accepted via the FURLS portal. All notifications must now be submitted in COSM.
Learn about the Recent Modifications to the Submission Processes for Structure/Function Claim Notifications.
Written Submissions
Written submissions are accepted. Information that is required in the submission includes:
- The name and address of the manufacturer, packer, or distributor of the dietary supplement product;
- the text of the statement that is being made;
- the name of the dietary ingredient or supplement that is the subject of the statement;
- the name of the dietary supplement (including the brand name); and
- the signature of a responsible individual or the person who can certify the accuracy of the information presented, and who must certify that the information contained in the notice is complete and accurate, and that the notifying firm has substantiation that the statement is truthful and not misleading.
Completed submissions should be mailed to:
Food and Drug Administration (HFS-810)
Office of Dietary Supplement Programs
5001 Campus Drive
College Park, MD 20740-3835
Questions?
If you have questions, please contact us at:
Office of Dietary Supplement Programs (HFS-810)
Center for Food Safety and Applied Nutrition
Food and Drug Administration
5001 Campus Drive
College Park, MD 20740-3835
Contact the Office of Dietary Supplement Programs by email at SFCN@fda.hhs.gov
To reach FDA’s Food and Cosmetics Information Center, call: 1-888-SAFEFOOD (1-888-723-3366)
Guidance for Industry
- Small Entity Compliance Guide on Structure/Function Claims
- Questions and Answers Regarding the Labeling of Dietary Supplements as Required by the Dietary Supplement and Nonprescription Drug Consumer Protection Act
- Small Entity Compliance Guide: Statement of Identity, Nutrition Labeling and Ingredient Labeling of Dietary Supplements